Clinical trials
Completed Phase 3 Asthma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
441 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 6 |
| 2002 | 26 |
| 2003 | 29 |
| 2004 | 29 |
| 2005 | 29 |
| 2006 | 26 |
| 2007 | 26 |
| 2008 | 16 |
| 2009 | 13 |
| 2010 | 23 |
| 2011 | 25 |
| 2012 | 21 |
| 2013 | 15 |
| 2014 | 25 |
| 2015 | 21 |
| 2016 | 15 |
| 2017 | 17 |
| 2018 | 17 |
| 2019 | 12 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 441 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 105 |
| GlaxoSmithKline | 52 |
| Organon and Co | 31 |
| Chiesi Farmaceutici S.p.A. | 20 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 20 |
| Novartis Pharmaceuticals | 16 |
| Boehringer Ingelheim | 15 |
| Sanofi | 15 |
| Milton S. Hershey Medical Center | 14 |
| Sumitomo Pharma America, Inc. | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 441 |
| Lung Diseases | 20 |
| Lung Diseases, Obstructive | 14 |
| Respiratory Tract Diseases | 14 |
| Bronchial Diseases | 13 |
| Pulmonary Disease, Chronic Obstructive | 7 |
| Dyspnea | 6 |
| Hypersensitivity | 6 |
| Rhinitis, Allergic | 6 |
| Pulmonary Eosinophilia | 5 |
Trials
Showing 1 to 25 of 441. Each trial links to its page on Pharma Observatory.
341 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.